公司资料
Foghorn Therapeutics 股价、新闻与催化剂
- 股票代码:
- FHTX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
6.74 USD (+7.67%)
收盘价
最后更新: 2026年8月17日
213M USD
市值
股价为何变动
As of Aug 17, 2026, FHTX closed up 7.67% at $6.74. No new same-company headline was identified in the current news window.
公司概览
业务概览
Foghorn Therapeutics is an oncology company focused on chromatin biology and gene-regulation targets. Its platform seeks to create differentiated cancer therapies through epigenetic control.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, Foghorn sits in specialty oncology biotechnology.
商业模式特征
The company depends on translational data, target validation, and the possibility of building a new oncology platform.
生物医药行业定位
Foghorn is a high-catalyst oncology name with strong dependence on early data quality.
未来催化剂
- Foghorn’s next three months are about its chromatin-regulation oncology programs and any data that show the platform can still produce differentiated human results. The market will care most about whether the synthetic-lethality thesis can keep moving forward.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。